PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 62 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $11,633,000 | +25.2% | 482,680 | 0.0% | 1.99% | +17.7% |
| Q1 2017 | $9,292,000 | +25.0% | 482,680 | 0.0% | 1.69% | -2.1% |
| Q4 2016 | $7,433,000 | +18.4% | 482,680 | 0.0% | 1.73% | +33.5% |
| Q3 2016 | $6,280,000 | -6.5% | 482,680 | 0.0% | 1.29% | -18.4% |
| Q2 2016 | $6,714,000 | -35.2% | 482,680 | -29.3% | 1.59% | -23.5% |
| Q1 2016 | $10,356,000 | -20.0% | 682,680 | 0.0% | 2.07% | -7.1% |
| Q4 2015 | $12,950,000 | -0.2% | 682,680 | 0.0% | 2.23% | -2.1% |
| Q3 2015 | $12,971,000 | -26.3% | 682,680 | 0.0% | 2.28% | -13.0% |
| Q2 2015 | $17,593,000 | -17.6% | 682,680 | 0.0% | 2.62% | -6.2% |
| Q1 2015 | $21,341,000 | -18.9% | 682,680 | 0.0% | 2.79% | -30.0% |
| Q4 2014 | $26,317,000 | – | 682,680 | – | 3.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,138,872 | $40,639,000 | 22.88% |
| Abingworth LLP | 1,301,413 | $24,701,000 | 14.43% |
| Roumell Asset Management, LLC | 201,845 | $3,835,000 | 7.78% |
| GREAT POINT PARTNERS LLC | 453,878 | $8,624,000 | 3.41% |
| Aisling Capital LLC | 682,680 | $12,971,000 | 2.28% |
| Broadfin Capital, LLC | 530,283 | $10,075,000 | 0.56% |
| Tekla Capital Management LLC | 762,581 | $14,489,000 | 0.52% |
| Baupost Group | 1,544,498 | $29,345,000 | 0.49% |
| GENERAL AMERICAN INVESTORS CO INC | 277,076 | $5,264,000 | 0.47% |
| Lombard Odier Asset Management (USA) Corp | 135,710 | $2,578,000 | 0.22% |